NZ624602A - Anhydrate of tiotropium bromide - Google Patents
Anhydrate of tiotropium bromideInfo
- Publication number
- NZ624602A NZ624602A NZ624602A NZ62460210A NZ624602A NZ 624602 A NZ624602 A NZ 624602A NZ 624602 A NZ624602 A NZ 624602A NZ 62460210 A NZ62460210 A NZ 62460210A NZ 624602 A NZ624602 A NZ 624602A
- Authority
- NZ
- New Zealand
- Prior art keywords
- tiotropium bromide
- anhydrous
- anhydrate
- anhydrous tiotropium
- compositions
- Prior art date
Links
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 title abstract 5
- 229960000257 tiotropium bromide Drugs 0.000 title abstract 5
- 239000012535 impurity Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- VPJFFOQGKSJBAY-UGTXJPTRSA-N scopine di(2-thienyl)glycolate Chemical compound C([C@@H]1N([C@H](C2)[C@@H]3[C@H]1O3)C)C2OC(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 VPJFFOQGKSJBAY-UGTXJPTRSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1048KO2009 | 2009-08-07 | ||
| NZ597920A NZ597920A (en) | 2009-08-07 | 2010-08-06 | Anhydrate of tiotropium bromide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ624602A true NZ624602A (en) | 2015-11-27 |
Family
ID=42830336
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ624602A NZ624602A (en) | 2009-08-07 | 2010-08-06 | Anhydrate of tiotropium bromide |
| NZ597920A NZ597920A (en) | 2009-08-07 | 2010-08-06 | Anhydrate of tiotropium bromide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ597920A NZ597920A (en) | 2009-08-07 | 2010-08-06 | Anhydrate of tiotropium bromide |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8697719B2 (esLanguage) |
| EP (1) | EP2462140A2 (esLanguage) |
| JP (2) | JP5822831B2 (esLanguage) |
| CN (1) | CN102639531B (esLanguage) |
| AU (1) | AU2010280497B2 (esLanguage) |
| CA (2) | CA2768553C (esLanguage) |
| IN (1) | IN2012DN00968A (esLanguage) |
| NZ (2) | NZ624602A (esLanguage) |
| WO (1) | WO2011015882A2 (esLanguage) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1869035E (pt) | 2005-12-19 | 2013-01-10 | Sicor Inc | Novas formas de brometo de tiotrópio e processos para sua preparação |
| US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| CN102639531B (zh) | 2009-08-07 | 2016-01-20 | 基因里克斯(英国)有限公司 | 噻托溴铵的无水合物 |
| TR201111589A2 (tr) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür susuz kristal formu. |
| PT106142B (pt) | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
| EP2897955B1 (en) * | 2012-09-11 | 2019-11-06 | Bilgic, Mahmut | New tiotropium bromide crystalline form |
| CN104341413A (zh) * | 2013-07-29 | 2015-02-11 | 天津金耀集团有限公司 | 一种无水噻托溴铵的新晶型 |
| AU2014352813A1 (en) * | 2013-11-22 | 2016-05-26 | Teva Branded Pharmaceutical Products R&D, Inc. | An inhalable medicament |
| EP2913332A1 (en) | 2014-02-27 | 2015-09-02 | Euticals S.P.A. | Crystalline form of tiotropium bromide with lactose |
| MX2019004366A (es) * | 2016-10-14 | 2019-08-05 | Glenmark Specialty Sa | Composiciones nebulizables de tiotropio y formoterol. |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US5610163A (en) | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| EP1468998A1 (de) | 2000-10-12 | 2004-10-20 | Boehringer Ingelheim Pharma GmbH & Co. KG | Kristallines Monohydrat von Tiotropiumbromid und Verfahren zu dessen Herstellung. |
| DE10064816A1 (de) | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
| US6506900B1 (en) | 2001-01-31 | 2003-01-14 | Boehringer Ingelheim Pharma Ag | Process for preparing a scopine ester intermediate |
| AUPR315301A0 (en) | 2001-02-19 | 2001-03-15 | Silverbrook Research Pty. Ltd. | An Apparatus (ART102) |
| US6608055B2 (en) | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| US6610849B2 (en) | 2001-06-28 | 2003-08-26 | Boehringer Ingelheim Pharma Kg | Process for the manufacture of tropenol |
| DE10200943A1 (de) | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Scopinestern |
| US6747153B2 (en) | 2002-05-31 | 2004-06-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Industrial process for preparing tropenol |
| JP4616264B2 (ja) | 2003-05-28 | 2011-01-19 | セラヴァンス， インコーポレーテッド | ムスカリン性レセプターアンタゴニストとしてのアザビシクロアルカン化合物 |
| HRP20100029T1 (hr) | 2003-11-03 | 2010-02-28 | Boehringer Ingelheim International Gmbh | Novi kristalinični anhidrid s antiholinergičkim učinkom |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| CN1271073C (zh) * | 2004-10-26 | 2006-08-23 | 江苏正大天晴药业股份有限公司 | 结晶性抗胆碱能药噻托溴铵晶体 |
| WO2006076222A2 (en) | 2005-01-10 | 2006-07-20 | Glaxo Group Limited | Pharmaceutical formulations |
| ES2393794T3 (es) | 2005-05-02 | 2012-12-28 | Boehringer Ingelheim International Gmbh | Nuevas formas cristalinas de bromuro de tiotropio |
| JP2008540367A (ja) | 2005-05-02 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規結晶性臭化チオトロピウム |
| DE102005035112A1 (de) | 2005-07-27 | 2007-02-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen |
| JP2008530251A (ja) * | 2005-12-19 | 2008-08-07 | シコール インコーポレイティド | 純粋且つ安定な臭化チオトロピウム |
| US20070167480A1 (en) | 2005-12-19 | 2007-07-19 | Sicor Inc. | Pure and stable tiotropium bromide |
| PT1869035E (pt) * | 2005-12-19 | 2013-01-10 | Sicor Inc | Novas formas de brometo de tiotrópio e processos para sua preparação |
| CN100410254C (zh) * | 2006-03-07 | 2008-08-13 | 南昌弘益科技有限公司 | 噻托溴铵无水物制备方法 |
| US20080051582A1 (en) | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
| WO2008089852A1 (de) | 2007-01-26 | 2008-07-31 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Neues verfahren zur herstellung von tiotropiumsalzen |
| HRP20110556T1 (hr) | 2007-02-21 | 2011-09-30 | Almirall | Novi postupci |
| WO2008104955A1 (en) | 2007-02-28 | 2008-09-04 | Ranbaxy Laboratories Limited | Azoniatricyclo [3.3.1.0] nonane derivatives as muscarinic receptor antagonists |
| AU2009203579B2 (en) | 2008-01-10 | 2013-07-25 | Generics [Uk] Limited | Novel process for the preparation of scopine esters |
| CN102639531B (zh) | 2009-08-07 | 2016-01-20 | 基因里克斯(英国)有限公司 | 噻托溴铵的无水合物 |
| WO2011015884A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Process to prepare scopine esters |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
| WO2011095800A2 (en) | 2010-02-02 | 2011-08-11 | Generics [Uk] Limited | Analytical methods |
-
2010
- 2010-08-06 CN CN201080044044.4A patent/CN102639531B/zh not_active Expired - Fee Related
- 2010-08-06 JP JP2012523394A patent/JP5822831B2/ja not_active Expired - Fee Related
- 2010-08-06 US US13/386,550 patent/US8697719B2/en not_active Expired - Fee Related
- 2010-08-06 AU AU2010280497A patent/AU2010280497B2/en not_active Ceased
- 2010-08-06 NZ NZ624602A patent/NZ624602A/en not_active IP Right Cessation
- 2010-08-06 NZ NZ597920A patent/NZ597920A/en not_active IP Right Cessation
- 2010-08-06 IN IN968DEN2012 patent/IN2012DN00968A/en unknown
- 2010-08-06 WO PCT/GB2010/051310 patent/WO2011015882A2/en not_active Ceased
- 2010-08-06 EP EP10743206.4A patent/EP2462140A2/en not_active Ceased
- 2010-08-06 CA CA2768553A patent/CA2768553C/en not_active Expired - Fee Related
- 2010-08-06 CA CA2931876A patent/CA2931876A1/en not_active Abandoned
-
2014
- 2014-04-07 US US14/246,291 patent/US9181268B2/en active Active
-
2015
- 2015-08-05 JP JP2015155158A patent/JP2015214574A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ597920A (en) | 2014-05-30 |
| US9181268B2 (en) | 2015-11-10 |
| CN102639531A (zh) | 2012-08-15 |
| AU2010280497A8 (en) | 2012-03-08 |
| CA2931876A1 (en) | 2011-02-10 |
| JP5822831B2 (ja) | 2015-11-24 |
| US20140249175A1 (en) | 2014-09-04 |
| JP2013501041A (ja) | 2013-01-10 |
| US8697719B2 (en) | 2014-04-15 |
| CA2768553A1 (en) | 2011-02-10 |
| WO2011015882A2 (en) | 2011-02-10 |
| CN102639531B (zh) | 2016-01-20 |
| JP2015214574A (ja) | 2015-12-03 |
| US20150051241A9 (en) | 2015-02-19 |
| CA2768553C (en) | 2016-08-02 |
| US20120149725A1 (en) | 2012-06-14 |
| AU2010280497A1 (en) | 2012-02-23 |
| AU2010280497B2 (en) | 2015-10-22 |
| IN2012DN00968A (esLanguage) | 2015-04-10 |
| WO2011015882A3 (en) | 2011-09-01 |
| EP2462140A2 (en) | 2012-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ624602A (en) | Anhydrate of tiotropium bromide | |
| PH12015500465A1 (en) | Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof | |
| JOP20210065A1 (ar) | عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة | |
| WO2011138281A3 (de) | Verfahren zur herstellung von dithiin-tetracarboxy-diimiden | |
| MY159252A (en) | Process for the preparation of dopo-derived compounds and compositions thereof | |
| CA2826751C (en) | Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds | |
| MX368263B (es) | Compuestos novedosos y composiciones farmaceuticas de los mismos para el tratamiento de fibrosis quistica. | |
| MX2014002031A (es) | Pirano[3,2-d][1,3]tiazol como inhibidores de glicosidasa. | |
| SG10201805198TA (en) | 18f - fluciclovine compositions in citrate buffers | |
| WO2012178129A3 (en) | Quaternary heteroatom containing compounds | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
| WO2011159903A3 (en) | Asenapine maleate | |
| MX348654B (es) | Composicion farmaceutica con biodisponibilidad mejorada para compuesto hidrofobico de alto punto de fusion. | |
| NZ607149A (en) | Galacto-oligosaccharide-containing composition and a method of producing it | |
| WO2011006875A3 (en) | Mineral fibres and their use | |
| IN2012DN01292A (esLanguage) | ||
| IN2012DN00765A (esLanguage) | ||
| MX352607B (es) | Proceso para la preparacion de benzoxaboroles. | |
| IN2014CN04449A (esLanguage) | ||
| NZ701237A (en) | Novel compounds and compositions for targeting cancer stem cells | |
| NZ628768A (en) | Process for preparing tiotropium bromide | |
| MY157423A (en) | Production method of intermediate compound for synthesizing medicament | |
| WO2015044853A3 (en) | Process for preparation of dimethyl fumarate | |
| WO2012007966A3 (en) | Process for preparation of intermediates of bendamustine | |
| IN2014DN03245A (esLanguage) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 06 AUG 2017 BY SPRUSON + FERGUSON Effective date: 20160329 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 AUG 2018 BY ENVOY INTERNATIONAL LIMITED Effective date: 20170717 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 AUG 2019 BY RENEWALS TEAM Effective date: 20180710 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 AUG 2020 BY RENEWALS TEAM Effective date: 20190729 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 AUG 2021 BY RENEWALS TEAM Effective date: 20200804 |
|
| LAPS | Patent lapsed |